Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome

Annals of Thoracic Medicine

Volumn 6, Issue 3, 2011, Pages 120-125

  Basoglu, Ozen K ^a   Sarac, Fulden ^a   Sarac, Sefa ^b   Uluer, Hatice ^a   Yilmaz, Candeger ^a  

^a EGE UNIVERSITY   (Turkey)

^b Department of Cardiology   (Turkey)

Author keywords

C reactive protein; fibrinogen; homocysteine; insulin resistance; leptin; metabolic syndrome; obesity; obstructive sleep apnea syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LEPTIN; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; APNEA HYPOPNEA INDEX; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY FAT; CARBON DIOXIDE TENSION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIOTHYRONINE BLOOD LEVEL; MALE; METABOLIC RATE; METABOLIC SYNDROME X; NECK; OBESITY; OXYGEN SATURATION; OXYGEN TENSION; PH; POLYSOMNOGRAPHY; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 80052905030     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.82440     Document Type: Article

References (48)

1. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: Implications for cardiac and vascular disease. JAMA 2003;290:1906-14. (Pubitemid 37430608)
2. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study, Sleep Heart Health Study. JAMA 2000;283:1829-36. (Pubitemid 30207619)
3. Ryan S, Taylor CT, McNicholas WT. Systemic infl ammation: A key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 2009;64:631-6.
4. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: The sleep heart health study. Am J Epidemiol 2004;160:521-30. (Pubitemid 39215628)
5. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004;25:735-41. (Pubitemid 38647933)
6. McNicholas WT. Obstructive sleep apnea and infl ammation. Prog Cardiovasc Dis 2009;51:392-9.
7. Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF. Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 2006;343:591-6.
8. Bhushan B, Guleria R, Misra A, Pandey RM, Luthra K, Vikram NK. Obstructive sleep apnoea correlates with C-reactive protein in obese Asian Indians. Nutr Metab Cardiovasc Dis 2009; 19:184-9.
9. Grunstein R, Wilcox I, Yang TS, Gould Y, Hedner J. Snoring and sleep apnoea in men: Association with central obesity and hypertension. Int J Obes Relat Metab Disord 1998;17:533-40. (Pubitemid 23269132)
10. Tan KC, Chow WS, Lam JC, Lam B, Wong WK, Tam S, et al. HDL dysfunction in obstructive sleep apnea. Atherosclerosis 2006;184:377-82. (Pubitemid 43049723)
11. Gami AS, Caples SM, Somers VK. Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 2003;32:869-94. (Pubitemid 38029985)
12. Punjabi NM, Sorkin JD, Katzel L, Goldberg A, Schwartz A, Smith PL. Sleep-disordered breathing and insulin resistance in middle aged and overweight men. Am J Respir Crit Care Med 2002;165:677-82. (Pubitemid 34194756)
13. Gruber A, Horwood F, Sithole J, Ali NJ, Idris I. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 2006;5:22-7.
14. Sharma SK, Kumpawat S, Coel A, Banga A, Ramakrishnan L, Chaturvedi P. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleepdisordered breathing. Sleep Med 2007;8:5-7.
15. Otake K, Sasanabe R, Hasegawa R, Banno K, Hori R, Okura Y, et al. Glucose intolerance in Japanese patients with obstructive sleep apnea. Intern Med 2009;48:1863-8.
16. Grosfeld A, Zilberfarb V, Turban S, Andre J, Guerre-Millo M, Issad T. Hypoxia increases leptin expression in human PAZ6 adipose cells. Diabetologia 2002;45:527-30. (Pubitemid 34533831)
17. Zamarron C, García Paz V, Riveiro A. Obstructive sleep apnea syndrome is a systemic disease. Current evidence. Eur J Intern Med 2008;19:390-8.
18. von Känel R, Dimsdale JE. Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 2003;124:1956-67. (Pubitemid 37433597)
19. Steiropoulos P, Papanas N, Nena E, Antoniadou M, Serasli E, Papoti S, et al. Inflammatory markers in middle-aged obese subjects: Does obstructive sleep apnea syndrome play a role? Mediators Infl amm 2010;2010:675320.
20. Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR. Circulating cardiovascular risk factors in obstructive sleep apnoea: Data from randomised controlled trials. Thorax 2004;59:777-82. (Pubitemid 39215375)
21. Ozkan Y, Firat H, Simsek B, Torun M, Yardim-Akaydin S. Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath 2008;12:149-54. (Pubitemid 351486675)
22. Yavuz Z, Ursavas A, Ege E, Ozarda Ilçol Y, Karadag M, Uzaslan E, et al. Homocysteine levels in patients with obstructive sleep apnea syndrome. Tuberk Toraks 2008;56:37-42.
23. Kapsimalis F, Varouchakis G, Manousaki A, Daskas S, Nikita D, Kryger M, et al. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. Lung 2008; 186:209-17.
24. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA 2002:287:356-9.
25. Akbartabartoori M, Lean ME, Hankey CR. Smoking combined with overweight or obesity markedly elevates cardiovascular risk factors. Eur J Card Preven 2006;13:938-46. (Pubitemid 44901156)
26. Izci B, Ardic S, Firat H, Sahin A, Altinors M, Karacan I. Reliability and validity studies of the Turkish version of the Epworth Sleepiness Scale. Sleep Breath 2008;12:161-8. (Pubitemid 351486676)
27. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring for Sleep Stages of Human Subjects. Los Angeles, Brain Information Service/Brain Research Institute, University of California, 1968.
28. nd edition: Diagnostic and coding manual. Westchester, Illinois: American Academy of Sleep Medicine, 2005.
29. Mohn A, Marcovecchio M, Chiarelli F. Validity of HOMA-IR as index of insulin resistance in obesity. J Pediatr 2006;148:565-6.
30. McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors in obstructive sleep apnea: A matched controlled study. Am J Respir Crit Care Med 2007;175:190-5. (Pubitemid 46115091)
31. McNicholas WT, Bonsigore MR; Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: Current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-78. (Pubitemid 46092013)
32. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008;29:2959-71.
33. Tasali E, Ip MS. Obstructive sleep apnea and metabolic syndrome: Alterations in glucose metabolism and infl ammation. Proc Am Thorac Soc 2008;5:207-17. (Pubitemid 351237880)
34. Davies RJ, Turner R, Crosby J, Stradling JR. Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring: Their comparison with matched controls and response to treatment. J Sleep Res 1994;3:180-5. (Pubitemid 24311373)
35. Stoohs RA, Facchini F, Guilleminault C. Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med 1996;154:170-4. (Pubitemid 26255785)
36. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002;165:670-6. (Pubitemid 34194755)
37. Zhang LQ, Yao WZ, Wang YZ, Ren B, Lin YP. Relationship between obstructive sleep apnea/hypopnea syndrome and insulin resistance. Zhonghua Nei Ke Za Zhi 2006;45:184-7.
38. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000;118:580-6.
39. Ursavas A, Ilcol YO, Nalci N, Karadag M, Ege E. Ghrelin, leptin, adiponectin, and resistin levels in sleep apnea syndrome: Role of obesity. Ann Thorac Med 2010;5:161-5.
40. Mojiminiyi OA, Al Mulla F, Abdella NA. Which obesity index best explains the link between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus? Med Princ Pract 2009;18:123-9.
41. Beasley LE, Koster A, Newman AB, Javaid MK, Ferrucci L, Kritchevsky SB, et al. Inflammation and race and gender differences in computerized tomography-measured adipose depots. Obesity (Silver Spring) 2009;17:1062-9.
42. Sarac F, Ozgen AG, Yilmaz C, Tuzun M. Cardiovascular risk factors in obese women and their fi rst-degree relatives. Anadolu kardiyol derg 2007;7:371-7. (Pubitemid 350303383)
43. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129-34. (Pubitemid 36297204)
44. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002;105:2462-4.
45. Chin K, Ohi M, Kita H, Noguchi T, Otsuka N, Tsuboi T, et al. Effects of NCPAP therapy on fi brinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996;153:1972-6. (Pubitemid 26187928)
46. Lavie L, Perelman A, Lavie P. Plasma homocysteine levels in obstructive sleep apnea: Association with cardiovascular morbidity. Chest 2001;120:900-8. (Pubitemid 32885467)
47. Svatikova A, Wolk R, Magera MJ, Shamsuzzaman AS, Phillips BG, Somers VK. Plasma homocysteine in obstructive sleep apnoea. Eur Heart J 2004;25:1325-9. (Pubitemid 38998509)
48. Jordan W, Berger C, Cohrs S, Rodenbeck A, Mayer G, Niedmann PD, et al. CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome. J Neural Transm 2004;111:683-9. (Pubitemid 38716548)